U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193277) titled 'Butylphthalide for Cognitive Impairment in Elderly Patients With Focal Epilepsy' on Sept. 10.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of butylphthalide soft capsules for treating cognitive impairment in elderly patients with focal epilepsy.
Study Population: 220 elderly patients (60-85 years) with focal epilepsy and mild to moderate cognitive impairment (Montreal Cognitive Assessment score 18-25).
Intervention: Participants will be randomly assigned 1:1 to receive either butylphthalide soft capsules (0.2g three times daily) or matching placebo for...